Anti-inflammatory glucocorticoid drugs: Reflections after 60 years

Inflammopharmacology

Volumn 19, Issue 1, 2011, Pages 1-19

  Whitehouse, Michael W ^a,b,c  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NONE   (Australia)

Author keywords

Adverse events; Alternatives to steroids; Arthritis; Asthma; Combination therapy; Corticosteroids; Cortisol corticosterone; Glucocorticoid; History of development; Inflammation; Inflammatory bowel diseases; Mechanisms of hormonal drug action; Natural medicines; Phytotherapeutics; Toxicities; Xenobiotic steroids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CATECHOLAMINE; CORTICOSTERONE; CORTISONE; DAPSONE; DEFLAZACORT; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCYRRHETINIC ACID; HYDROCORTISONE; HYDROCORTISONE DERIVATIVE; LIPOXYGENASE INHIBITOR; MACROLIDE; METHYLPREDNISOLONE; MONTELUKAST; PARAMETHASONE; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; STEROID; THEOPHYLLINE; TRIAMCINOLONE; UNINDEXED DRUG; XENOBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BEHAVIOR DISORDER; BIOASSAY; BRAIN INJURY; CARBOHYDRATE METABOLISM; CATARACT; CHRONIC DISEASE; CLEFT LIP; CLEFT PALATE; DETOXIFICATION; DIABETES MELLITUS; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HYDROXYLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG OXIDATION; DRUG RECEPTOR BINDING; DRUG RESISTANCE; ENDOCRINE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; EYE DISEASE; FEEDBACK SYSTEM; FLUID BALANCE; GASTROINTESTINAL DISEASE; GENE INTERACTION; GLAUCOMA; GLUCOSE TRANSPORT; GROWTH RETARDATION; HAIR GROWTH; HOMEOSTASIS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; HUMAN; HYPERGLYCEMIA; HYPERSENSITIVITY; HYPERTENSION; IMMUNE RESPONSE; INFECTION; INFLAMMATORY DISEASE; INJURY; LIPID METABOLISM; LOW DRUG DOSE; MENTAL DISEASE; METABOLIC DISORDER; MONOTHERAPY; MUSCULOSKELETAL DISEASE; MYOPATHY; NEUROENDOCRINE SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; OSTEOPOROSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN METABOLISM; PSYCHOSIS; REGULATORY MECHANISM; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ATROPHY; SKIN DISEASE; SKIN ULCER; TERATOGENICITY; THERAPY DELAY; TISSUE REGENERATION; ULCEROGENESIS; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFLAMMATION;

EID: 79951812796     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-010-0056-2     Document Type: Review

References (140)

1. IM Adcock PJ Barnes 2008 Molecular mechanisms of corticosteroid resistance Chest 134 394 401 1:CAS:528:DC%2BD1cXhtVOgu7bF 18682458 10.1378/chest.08-0440
2. Albrechtsen SJ (1991) Philip Showalter Hench. In: Magill FN (ed) The nobel prize winners: physiology or medicine, vol 2. Salem Press, Pasadena CA, pp 627-635
3. Z Alourfi RP Donn A Stevens A Berry A McMaster DW Ray 2005 Glucocorticoids suppress macrophage migration inhibitor factor (MIF) expression in a cell-type-specific manner J Mol Endocrinol 34 583 595 1:CAS:528: DC%2BD2MXjslGgs74%3D 15821118 10.1677/jme.1.01647 (Pubitemid 40585203)
4. Auphan N, DiDonato JA, Rosette C, Heimberg A, Karin M (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-209
5. JR Baker GS Barsh DH Carney DD Cunningham 1978 Dexamethasone modulates binding and action of epidermal growth factor in serum-free cultures Proc Natl Acad Sci USA 75 1882 1886 1:CAS:528:DyaE1cXktFOgs7o%3D 306107 10.1073/pnas.75.4.1882 (Pubitemid 8337574)
6. PJ Barnes 2006 How corticosteroids control inflammation Br J Pharmacol 148 245 254 1:CAS:528:DC%2BD28XltVCjt74%3D 16604091 10.1038/sj.bjp.0706736 (Pubitemid 43804814)
7. D Barraclough 1983 Rheumatoid arthritis Austr Fam Physician 12 Suppl 2 10
8. B Bartholome CM Spies T Gaber S Schuchmann T Berki D Kunkel, et al. 2004 Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis FASEB J 18 70 80 1:CAS:528: DC%2BD2cXmt1Knsw%3D%3D 14718388 10.1096/fj.03-0328com (Pubitemid 38076467)
9. DL Berliner N Keller TF Dougherty 1961 Tissue retention of cortisol and metabolites induced by ACTH: an extra adrenal effect Endocrinol 68 621 632 1:CAS:528:DyaF3MXns12ltA%3D%3D 10.1210/endo-68-4-621
10. JW Bijlsma KG Saag F Buttgereit JAP da Silva 2005 Developments in glucocorticoid therapy Rheum Dis Clin N Am 31 1 17 10.1016/j.rdc.2004.10.003 (Pubitemid 40082051)
11. JR Borski 2000 Nongenomic membrane actions of glucocorticoids in vertebrates Trends Endocrinol Metab 11 427 436 1:CAS:528:DC%2BD3cXot12ku7c%3D 11091121 10.1016/S1043-2760(00)00325-8
12. H Bostrom E Odeblad 1953 The influence of cortisone upon sulphate exchange of chondroitin sulfuric acid Arkiv Kemi 6 39 43 1:CAS:528: DyaG3sXltFKqtA%3D%3D
13. P Brandtzaeg 1996 History of oral tolerance and mucosal immunity Ann NY Sci 778 1 27 1:CAS:528:DyaK28XjtVClsbc%3D 10.1111/j.1749-6632.1996.tb21110.x (Pubitemid 26145528)
14. JM Braughler 1985 Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes; protection by glucocorticoids J Neurochem 44 1282 1288 1:CAS:528:DyaL2MXhsl2gtrk%3D 3882888 10.1111/j.1471-4159.1985.tb08755.x (Pubitemid 15107070)
15. JM Braughler JF Pregenzer 1989 The novel 21-aminosteroid inhibitors of lipid peroxidation: reaction with lipid peroxyl and phenoxyl radicals Free Radic Biol Med 7 125 130 1:CAS:528:DyaK3MXksVWqtrg%3D 2806938 10.1016/0891-5849(89) 90003-8 (Pubitemid 19220710)
16. IE Bush 1962 Chemical and biological factors in the activity of adrenocorticoid steroids Pharmacol Rev 14 317 445 1:CAS:528:DyaF3sXhtVOqtA%3D%3D 14017298
17. D Butters M Whitehouse 2009 Beyond DMARDs: extending TNF-regulant therapies to the vast majority/less privileged Int J Rheum Dis 12 299 306 20374366 10.1111/j.1756-185X.2009.01427.x
18. F Buttgereit A Schaffold 2002 Rapid glucocorticoid effects on immune cells Steroids 67 529 534 1:CAS:528:DC%2BD38XivVahtrY%3D 11960631 10.1016/S0039-128X(01)00171-4 (Pubitemid 34311770)
19. F Buttgereit KG Saag M Cutolo JA da Silva JW Bijlsma 2005 The molecular basis for the effectiveness, toxicity and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis Scand J Rheumatol 34 14 21 1:CAS:528:DC%2BD2MXjsVOmtr0%3D 15903020 10.1080/03009740510017706 (Pubitemid 40445053)
20. F Buttgereit G Doering A Schaeffler S Witte S Sierakowski E Gromnica-Ihle, et al. 2010 Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis Ann Rheum Dis 69 1275 1280 1:CAS:528:DC%2BC3cXhtVSltbfO 20542963 10.1136/ard.2009.126888
21. JR Caldwell DE Furst 1991 The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis Sem Arthr Rheum 21 1 11 1:STN:280:DyaK38%2FlsVKhtw%3D%3D 10.1016/0049-0172(91)90051-Z
22. G Cardinali G Cardinali BM Decaro AH Handler M Aboul-Enein 1964 Effect of high doses of cortisone on bone marrow cell proliferation in the Syrian hamster Cancer Res 24 969 972 1:STN:280:DyaF2c7ltlersw%3D%3D 14195349
23. CW Castor EL Dorstewitz 1966 Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. I. Relative unresponsiveness of rheumatoid synovial cells to hydrocortisone J Lab Clin Med 68 300 313 1:STN:280:DyaF2s%2FgtlOitA%3D%3D 5912603
24. E Charmandari T Kino T Ichijo GP Chrousos 2008 Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder J Clin Endocrinol Metab 93 1563 1572 1:CAS:528: DC%2BD1cXlvFWhu7o%3D 18319312 10.1210/jc.2008-0040 (Pubitemid 351656488)
25. MY Cheng G Sun M Jin H Zhao GK Steinberg RM Sapolsky, et al. 2009 Blocking glucocorticoid and enhancing estrogenic genomic signalling protects against cerebral ischemia J Cereb Blood Flow Metab 29 130 136 1:CAS:528:DC%2BD1MXht1amsA%3D%3D 18797472 10.1038/jcbfm.2008.105
26. IC Chickanza DL Kozaci 2004 Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives Rheumatology 43 1337 1345 10.1093/rheumatology/keh333 (Pubitemid 39480919)
27. MJ Coghlan SW Elmore PR Kym ME Kort 2003 The pursuit of differentiated ligands for the glucocorticoid receptor Curr Top Med Chem 3 1617 1635 1:CAS:528:DC%2BD3sXotFKltrw%3D 14683518 10.2174/1568026033451718
28. MJ Coghlan PB Jacobson B Lane M Nakane CW Lin SW Elmore, et al. 2003 A novel anti-inflammatory maintained glucocorticoid efficacy with reduced side effects Mol Endocrinol 17 860 869 1:CAS:528:DC%2BD3sXktFKnur4%3D 12586843 10.1210/me.2002-0355 (Pubitemid 36546214)
29. IR Cohen 2000 Discrimination and dialogue in the immune system Semin Immunol 12 215 219 1:STN:280:DC%2BD3cvlsVymtg%3D%3D 10910742 10.1006/smim.2000.0234 (Pubitemid 30479441)
30. IR Cohen EL Klareskog 2008 Anti-inflammatory therapy for rheumatoid arthritis Arthr Rheum 58 1 4 10.1002/art.23212
31. Cowell A-M, Buckingham JL (2001) Glucocorticoids and the HPA-axis. In: Goulding NJ, Flower RJ (eds) Glucocorticoids. Birkhauser Verlag, Basel, pp 129-145
32. PR Cury VC Araujo F Canavez C Furuse NS Araujo 2007 Hydrocortisone affects the expression of matrix metalloproteinases (MMP-1,-2,-3,-7, and -11) and tissue inhibitor of matrix metalloproteinases (TIMP-1) in human gingival fibroblasts J Periodontol 78 1309 1315 17608586 10.1902/jop.2007.060225
33. JA Da Silva JW Jacobs JR Kirwan M Boers KG Saag LB Inês, et al. 2006 Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Ann Rheum Dis 65 285 293 1:CAS:528:DC%2BD28XisFCjt78%3D 16107513 10.1136/ard.2005.038638 (Pubitemid 43268214)
34. K De Bosscher G Haegeman 2009 Minireview: latest perspectives on antiinflammatory actions of glucocorticoids Mol Endocrincol 23 281 291 10.1210/me.2008-0283 1:CAS:528:DC%2BD1MXjtFGltr4%3D
35. 35S in the stomach J Lab Clin Med 51 174 177 1:CAS:528: DyaG1cXjs1OntA%3D%3D 13514222
36. Derbes VJ, Weiss TE (1951) Untowards reactions of cortisone and ACTH. Oxford Blackwells Scientific Publications, 51 pp
37. J-P Devogelaer 2006 Glucocorticoid-induced osteoporosis: mechanisms and therapeutic approach Rheum Dis Clin N Am 32 733 757 10.1016/j.rdc.2006.09.001 (Pubitemid 46621087)
38. TF Dougherty DL Berliner ML Berliner 1961 Corticosteroid-tissue interactions Metabolism 10 966 987
39. M Einstein M Greenlee G Rouen A Sitlani J Santoro C Wang, et al. 2004 Selective glucocorticoid receptor nonsteroidal ligands completely antagonize the dexamethasone-mediated induction of enzymes involved in gluconeogenesis and glutamine metabolism J Steroid Biochem Mol Biol 92 345 356 1:CAS:528: DC%2BD2MXptleluw%3D%3D 15698539 10.1016/j.jsbmb.2004.10.009 (Pubitemid 40187152)
40. AMM Eisjbouts EP Murphy 1999 The role of the hypothalamic-pituitary- adrenal axis in rheumatoid arthritis Best Pract Res Clin Rheumatol 13 599 613 10.1053/berh.1999.0048 (Pubitemid 30050430)
41. Fieser LF, Fieser M (1959) Adrenocortical hormones. In: Steroids. Rheinhold Publication Corporation, New York, pp 600-726
42. L Filaretova T Podvigina T Bagaeva O Morozova 2009 Dual action of glucocorticoid hormones on the gastric mucosa: how the gastroprotective action can be transformed to the ulcerogenic one Inflammopharmacol 17 15 22 1:CAS:528:DC%2BD1MXhtFelu7w%3D 10.1007/s10787-008-8046-3
43. Florey HW (1962) Influence of drugs on the inflammatory process. In: Florey HW (ed) General pathology, 3rd edn. Lloyd-Luke (Med Books), London, pp 1050-1052
44. FC Fraser A Sajoo 1995 Teratogenic potential of corticosteroids in humans Teratology 52 45 46 10.1002/tera.1420510107
45. S Furukawa K Usada M Abe I Ogawa 2004 Histopathological findings of cleft palate in rat embryos induced by triamcinolone acetonide J Vet Med Sci 66 397 402 1:CAS:528:DC%2BD2cXksVWjt78%3D 15133269 10.1292/jvms.66.397 (Pubitemid 41380309)
46. P Ghosh S Shimmon MW Whitehouse 2006 Arthritic disease suppression and cartilage protection with glycoaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy Inflammopharmacol 14 155 162 1:CAS:528:DC%2BD28XhtVynsbjO 10.1007/s10787-006- 1522-8 (Pubitemid 44358282)
47. EC Gomez P Frost 1976 Induction of glycosuria and hyperglycaemia by topical corticosteroid therapy Arch Dermatol 112 1559 1562 1:STN:280: DyaE2s%2FktlKiuw%3D%3D 984862 10.1001/archderm.112.11.1559
48. JA Gonzalo A Gonzalez-Garcia C Martinez G Kroemer 1993 Glucocorticoid mediated control of the activation of and clonal deletion of peripheral T cells in vivo J Exp Med 177 1239 1245 1:CAS:528:DyaK3sXitVGms7s%3D 8478606 10.1084/jem.177.5.1239
49. V Gossye D Elewaut K van Breneden P Dewint G Haegeman K de Bosscher 2010 A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance Ann Rheum Dis 69 291 296 1:CAS:528:DC%2BC3cXhtFOlsbw%3D 19204014 10.1136/ard.2008.102871
50. NJ Goulding 1998 Corticosteroids-a case of mistaken identity Br J Rheumatol 37 477 483 1:STN:280:DyaK1czhtlSqsw%3D%3D 9651071 10.1093/ rheumatology/37.5.477
51. KL Gross JA Cidlowski 2008 Tissue-specific glucocorticoid action: a family affair Trends Endocrinol Metab 19 331 339 1:CAS:528:DC%2BD1cXht1KltrfF 18805703 10.1016/j.tem.2008.07.009
52. WJ Halliday JS Garvey 1964 Some factors affecting the secondary immune response in tissue cultures containing hydrocortisone J Immunol 93 957 962
53. SJ Harbison MW Whitehouse 2000 Possible steroid-sparing effect of Lyprinol, a shellfish lipid extract Med J Austr 173 560 1:STN:280: DC%2BD3M7gtVCjtA%3D%3D
54. MS Harbuz DOS Jessep 1999 Is there a deficit in cortisol production in rheumatoid arthritis? Rheumatology 38 298 302 1:CAS:528:DyaK1MXjslOmtrs%3D 10378704 10.1093/rheumatology/38.4.298 (Pubitemid 29507176)
55. R Hardy EH Rabbitt A Filer P Emery M Hewison PM Stewart, et al. 2008 Local and systemic glucocorticoid metabolism in inflammatory arthritis Ann Rheum Dis 67 1204 1210 1:CAS:528:DC%2BD1cXhtFGhtL7I 18420938 10.1136/ard.2008.090662
56. PS Hench EC Kendall CH Slocumb HF Polley 1950 Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions Arch Int Med 85 545 666 1:CAS:528:DyaG3cXivVSjsA%3D%3D
57. MR Hetland IJ Christensen U Tarp L Dreyer A Hansen IB Hansen, et al. 2010 Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept or infleximab Arthr Rheum 62 22 32 1:CAS:528:DC%2BC3cXhtFGnurnP 10.1002/art.27227
58. SG Hillier 2007 Diamonds are forever: the cortisone legacy J Endocrinol 195 1 6 1:CAS:528:DC%2BD2sXhtlWiurfM 17911391 10.1677/JOE-07-0309 (Pubitemid 350055993)
59. JN Hoes JWG Jacobs M Boers D Boumpas F Buttgereit N Caeyers, et al. 2007 EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases Ann Rheum Dis 66 1560 1567 1:STN:280:DC%2BD2snmvVKktA%3D%3D 17660219 10.1136/ard.2007.072157 (Pubitemid 350205441)
60. JN Hoes JWG Jacobs SMM Verstalppen JW Bijlsma GJMG Van der Heij den 2009 Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis Ann Rheum Dis 68 1833 1838 1:CAS:528: DC%2BD1MXhsF2itr%2FJ 19066177 10.1136/ard.2008.100008
61. TG Hoffman SP Hehner S Bacher W Droge ML Schmitz 1998 Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kB dependent transcription FEBS Lett 441 441 446 10.1016/S0014-5793(98)01609-3 (Pubitemid 29065331)
62. S Hundertmark H Buhler M Rudolf HK Weitzel V Ragosch 1997 Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells J Endocrinol 155 171 180 1:CAS:528:DyaK2sXmsV2gu7c%3D 9390020 10.1677/joe.0. 1550171 (Pubitemid 27428319)
63. E Hyun M Bulla M Steinhoff JL Wallace P del Soldato N Vergnolle 2004 Anti-inflammatory effect of nitric oxide-releasing hydrocortisone NXC-1 022 in a murine model of contact dermatitis Br J Pharmacol 143 618 625 1:CAS:528:DC%2BD2cXhtVWitLzN 15313880 10.1038/sj.bjp.0705854 (Pubitemid 39524280)
64. DJ Ingle 1954 Permissibility of hormone action; a review Acta Endocrinol 17 172 186 1:CAS:528:DyaG2MXitVyntg%3D%3D 13227827
65. RJ Kavenagh PCA Kam 2001 Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection Br J Anaesth 86 110 119 10.1093/bja/86.1.110 (Pubitemid 32015592)
66. EC Kendall 1951 The adrenal cortex and rheumatoid arthritis Br Med J 2 1295 1299 1:STN:280:DyaG38%2FgvFWrsg%3D%3D 14879070 10.1136/bmj.2.4743.1295
67. JR Kirwan 2007 Glucocorticoid resistance in patients with rheumatoid arthritis Scand J Rheumatol 36 165 166 1:CAS:528:DC%2BD2sXotVOiu7w%3D 17657667 10.1080/03009740701340263 (Pubitemid 47174542)
68. J Kirwan L Power 2007 Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis Curr Opin Rheumatol 19 233 237 1:CAS:528:DC%2BD2sXjvFClt7w%3D 17414948 10.1097/BOR.0b013e3280d6471a (Pubitemid 46597459)
69. M Leech C Metz P Hall P Hutchinson K Gianis M Smith, et al. 2001 Macrophage inhibitory factor in rheumatoid arthritis: evidence of pro-inflammatory function and regulation by glucocorticoids Arthr Rheum 42 1601 1608 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B (Pubitemid 30263626)
70. AC Liberman J Druker FA Garcia F Holsboer E Arzt 2009 Intracellular molecular signalling. Basis for specificity to glucocorticoid anti-inflammatory actions Ann NY Acad Sci 1153 6 13 1:CAS:528:DC%2BD1MXjs1Ontrk%3D 19236322 10.1111/j.1749-6632.2008.03958.x
71. GC Liggins RN Howie 1972 A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants Pediatrics 50 515 525 1:STN:280:DyaE3s%2FgvVCrtw%3D%3D 4561295
72. PE Lipsky XL Tao 1997 A potential new treatment for rheumatoid arthritis: thunder god vine Semin Arthr Rheum 26 713 723 1:STN:280:DyaK2s3ptVSlsQ%3D%3D 10.1016/S0049-0172(97)80040-6 (Pubitemid 27190960)
73. C-G Lofdahl TF Reiss JA Leff E Israel MJ Noonan AF Finn, et al. 1999 Randomised placebo controlled trial of effect of a leukotrienes receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients Br Med 19 87 90 (Pubitemid 29313237)
74. GD Martich RL Danner M Ceska AF Suffredini 1991 Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents J Exp Med 173 1021 1024 1:CAS:528: DyaK3MXhsVWhurc%3D 2007851 10.1084/jem.173.4.1021
75. LS McKenzie BA Horsburgh P Ghosh TKF Taylor 1976 Effect of anti-inflammatory drugs on sulphated glycoaminoglycan synthesis in aged human cartilage Ann Rheum Dis 35 487 497 1:CAS:528:DyaE2sXhtVSqsbc%3D 1008617 10.1136/ard.35.6.487 (Pubitemid 8007238)
76. MA McKenzie WH Hoefnagels RW Jansen TJ Benraad PW Kloppenborg 1990 The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers J Clin Endocrinol Metab 70 1637 1645 10.1210/jcem-70-6-1637
77. JN Miner 2002 Designer glucocorticoids Biochem Pharmacol 64 355 361 1:CAS:528:DC%2BD38XlvVWms78%3D 12147285 10.1016/S0006-2952(02)01121-8 (Pubitemid 34879086)
78. R Mitra RM Sapolsky 2008 Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy Proc Natl Acad Sci USA 105 5573 5578 1:CAS:528:DC%2BD1cXkslSnt74%3D 18391224 10.1073/pnas.0705615105 (Pubitemid 351753904)
79. LA Moraes PJ Paul-Clark A Richman RJ Flower NJ Goulding M Perretti 2005 Ligand-specific glucocorticoid receptor activation in human platelets Blood 106 4167 4175 1:CAS:528:DC%2BD2MXhtlaltr3L 16131566 10.1182/blood-2005-04-1723 (Pubitemid 41775923)
80. EF Morand M Leech 2001 Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis Immunol Cell Biol 79 395 399 1:CAS:528:DC%2BD3MXmsVOns7k%3D 11488987 10.1046/j.1440-1711.2001.01028.x (Pubitemid 32744285)
81. Y Morita A Munck 1964 Effect of glucocorticoids in vivo and in vitro on net glucose uptake and amino acid incorporation by rat thymus cells Biochim Biophys Acta 93 150 157 1:CAS:528:DyaF2cXkvFeru7o%3D 14249140
82. ME Mummert 2005 Immunological roles of hyaluran Immunol Res 31 189 206 1:CAS:528:DC%2BD2MXkslymtb0%3D 15888911 10.1385/IR:31:3:189 (Pubitemid 40628957)
83. Munck A (2001) Historical introduction. In: Goulding NJ, Flower R (eds) Glucocorticoids (milestones in drug therapy). Basel Birkhauser Verlag, pp 17-34
84. A Munck A Naray-Fejes-Toth 1992 The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited Mol Cell Endocrinol 90 C1 C4 1:CAS:528:DyaK3sXhs1ertA%3D%3D 1301388 10.1016/0303-7207(92)90091-J
85. A Munck PM Guyre NJ Holbrook 1984 Physiological functions of glucocorticoids in stress and their relation to pharmacological actions Endocr Rev 5 25 44 1:CAS:528:DyaL2cXhvVGrtrk%3D 6368214 10.1210/edrv-5-1-25
86. S Nalbant I Akmaz M Kaplan K Avsar E Solmazgul B Sahan 2006 Does rofecoxib increase TNF-alpha levels? Clin Exp Rheumatol 24 361 365 1:STN:280:DC%2BD28rmtVKksQ%3D%3D 16956424 (Pubitemid 44363535)
87. L Naumann D Huscher J Detert M Spengler G-R Burmester F Buttgereit 2009 Anti-TNFα therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticocoid treatment Ann Rheum Dis 68 1234 1236 10.1136/ard.2009.111807 1:CAS:528:DC%2BD1MXhsF2itrrI
88. S Nayak B Acharjya 2008 Deflazacort versus other glucocorticoids: a comparison Indian J Dermatol 53 167 170 19882026 10.4103/0019-5154.44786
89. R Newton R Leigh MA Giembycz 2010 Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases Pharmacol Ther 125 286 327 1:CAS:528:DC%2BC3cXitVKjtrw%3D 19932713 10.1016/j.pharmthera.2009.11.003
90. AW Norman MT Mizwicki DP Norman 2004 Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model Nat Rev Drug Discov 3 27 41 1:CAS:528:DC%2BD2cXpvFKquw%3D%3D 14708019 10.1038/nrd1283 (Pubitemid 38088696)
91. VF Panoulas KM Douglas A Stavropoulos-Kalinoglou GS Metsios P Nightingale, et al. 2008 Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology (Oxford) 27 72 75 10.1093/rheumatology/kem311 1:CAS:528: DC%2BD1cXhtVygtQ%3D%3D (Pubitemid 350286266)
92. CM Pariante 2008 The role of multi-drug resistance p-glycoprotein in glucocorticoid function: studies in animals and relevance in humans Eur J Pharmacol 583 263 271 1:CAS:528:DC%2BD1cXjs1Squ7Y%3D 18275949 10.1016/j.ejphar.2007.11.067
93. MJ Paul-Clark L Mancini P del Soldato 2006 Potent anti-arthritic properties of a glucocorticoid derivative (NCS-1015) in an experimental model of arthritis Proc Natl Acad Sci USA 99 1677 1682 10.1073/pnas.022641099 1:CAS:528:DC%2BD38Xht1CltLo%3D (Pubitemid 34136552)
94. A Pazirandeh Y Xue J Rafter J Sjovall M Jondal S Okrets 1999 Paracrine glucocorticoid activity produced by mouse thymic epithelial cells FASEB J 13 893 901 1:CAS:528:DyaK1MXjtFGks7s%3D 10224232 (Pubitemid 29220701)
95. Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P et al. (2006) Comparison of treatment effects between animal experiments and clinical trials: systematic review. Br Med J. doi: 10:1136/bmj.39048.407928.BE (publ. 15 December 2006)
96. M Perretti F D'Acquiolo 2009 Annexin-A1 and glucocorticoids as effectors of the resolution of inflammation Nat Rev Immunol 9 62 70 1:CAS:528: DC%2BD1cXhsFartbzP 19104500 10.1038/nri2470
97. MG Perry JR Kirwan DS Jessop LP Hunt 2009 Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis Ann Rheum Dis 68 63 68 1:CAS:528: DC%2BD1MXhslOlt7w%3D 18375536 10.1136/ard.2007.086561
98. HH Petersen TK Andreassen T Breiderhofft JH Brasen H Schultz V Gross, et al. 2006 Hyporesponsiveness to glucocorticoids in mice genetically deficient for the corticosteroid binding globulin Mol Cell Biol 26 7236 7245 1:CAS:528:DC%2BD28XhtVCltbfO 16980625 10.1128/MCB.00400-06 (Pubitemid 44477699)
99. Popper TL, Watnick AS (1974) Anti-inflammatory steroids In: Scherrer RA, Whitehouse MW (eds) Anti-inflammatory agents, vol I. Academic Press, New York, pp 245-294
100. V Premkumar M Dey R Dorn I Raskin 2010 MyD88-dependant and independent pathways of toll-like receptors are engaged in biological activity of triptolide in ligand-stimulated macrophages BMC Chem Biol 10 3 20385024 10.1186/1472-6769-10-3 1:CAS:528:DC%2BC3cXlsVyku70%3D
101. SJ Quirk JE Gannell MJ Fullerton JW Funder 1986 Specificity and mechanism of biphasic action of glucocorticoids on alpha-lactabumin production by rat mammary gland explants Endocrinology 118 909 914 1:CAS:528:DyaL28Xht1egu7Y%3D 3948779 10.1210/endo-118-3-909 (Pubitemid 16080117)
102. Rainsford KD (2005) The Coxib controversies. Inflammopharmacol 13:331-341
103. Rainsford KD (2008) Review of "The resolution of inflammation". In: Rossi AG, Sawatsky DA (eds) Inflammopharmacol, vol 16, Birkhauser, Basel, pp 100-102
104. T Rhen JA Cidlowski 2005 Anti-inflammatory action of glucocorticoids-new mechanisms for old drugs New Engl J Med 353 1711 1723 1:CAS:528: DC%2BD2MXhtFansrrI 16236742 10.1056/NEJMra050541 (Pubitemid 41464710)
105. EM Richard J-C Helbling C Tridon A Dermedt AM Minni M Cador, et al. 2010 Plasma transcortin influences endocrine and behavioural stress responses in mice Endocrinol 151 649 659 1:CAS:528:DC%2BC3cXhsVOquro%3D 10.1210/en.2009-0862
106. MR Rubin JP Bilezikian 2003 New anabolic therapies in osteoporosis Endocrinol Metab Clin N Am 32 285 307 1:CAS:528:DC%2BD3sXjtFOjtr8%3D 10.1016/S0889-8529(02)00056-7 (Pubitemid 36378646)
107. T Sadowski J Steinmeyer 2001 Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes Osteoarthr Cartil 9 407 415 1:STN:280:DC%2BD3MvitVKhsA%3D%3D 11467888 10.1053/joca.2000.0406 (Pubitemid 32734343)
108. C Saldanha G Tougas E Grace 1986 Evidence for anti-inflammatory effect of normal circulating plasma cortisol Clin Exp Rheumatol 4 365 366 1:STN:280:DyaL2s%2FnvFSrsA%3D%3D 3791721 (Pubitemid 17223176)
109. MJM Schaaf JA Cidlowski 2002 Molecular mechanisms of glucocorticoid action and resistance J Steroid Biochem Mol Biol 83 37 48 1:CAS:528: DC%2BD3sXitFahsrw%3D 12650700 10.1016/S0960-0760(02)00263-7 (Pubitemid 37040640)
110. H Schacke A Schottelius W Docke P Strehlke S Jaroch N Schmees, et al. 2004 Dissociation of transactivation from transrepression by a selective glucocorticoid agonist leads to separation of therapeutic effects from side effects Proc Natl Acad Sci USA 101 227 232 14694204 10.1073/pnas.0300372101 1:CAS:528:DC%2BD2cXjvFantg%3D%3D (Pubitemid 38084232)
111. H Schacke M Berger M Rehwinkel K Asadullah 2007 Selective glucocorticoid agonists (SEGRAs): novel ligands with improved therapeutic index Mol Cell Endocrinol 275 109 117 17630119 10.1016/j.mce.2007.05.014 1:CAS:528: DC%2BD2sXpt1Sktb8%3D (Pubitemid 47259282)
112. H Schäcke WD Döcke K Asadullah 2002 Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 23 43 12441176 10.1016/S0163-7258(02)00297-8 (Pubitemid 35346616)
113. S Schiller A Dorfman 1957 Mucopolysaccharides in animals: the effect of cortisone and hydrocortisone on rat skin Endocrinology 60 376 381 1:CAS:528:DyaG2sXksVelsg%3D%3D 13404971 10.1210/endo-60-3-376
114. M Schmidt RH Straub 2007 Altered expression of 11β-hydroxysteroid dehydrogenases in rheumatoid arthritis synovial cells Arthritis Rheum 55 1720 1721 10.1002/art.22642 1:CAS:528:DC%2BD2sXmsFartbo%3D (Pubitemid 46764105)
115. WM Selenke GW Leung RG Townley 1980 Non-antibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin class with special reference to their "steroid-sparing" effects J Allergy Clin Immunol 65 454 464 1:CAS:528:DyaL3cXlt1GmtbY%3D 6966289 10.1016/0091-6749(80)90239-0 (Pubitemid 10125234)
116. H Selye 1946 The general adaption syndrome and the diseases of adaption J Clin Endocrinol 6 117 230 1:CAS:528:DyaH28XhvFGmug%3D%3D 10.1210/jcem-6-2-117
117. VL Shepherd MG Konish P Stahl 1985 Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages J Biol Chem 260 160 164 1:CAS:528:DyaL2MXptVamsw%3D%3D 3965445 (Pubitemid 15165296)
118. JS Smolen R Landewe FC Breedveld M Dougados P Emery C Gaujoux-Viala, et al. 2010 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Ann Rheum Dis 69 964 975 1:CAS:528:DC%2BC3cXos1GiurY%3D 20444750 10.1136/ard.2009.126532
119. Sneader W (2005) Adrenal cortex hormones. In: Drug discovery, a history. Wiley, Chichester, pp 179-184
120. SF Sorrells RM Sapolsky 2007 An inflammatory review of glucocorticoid actions in the CNS Brain Behav Immun 21 259 272 1:CAS:528:DC%2BD2sXhs1Smt7Y%3D 17194565 10.1016/j.bbi.2006.11.006 (Pubitemid 46199119)
121. CM Spies JWJ Bijlsma G-R Burmester F Buttgereit 2010 Pharmacology of glucocorticoids in rheumatoid arthritis Curr Opin Pharmacol 10 302 307 1:CAS:528:DC%2BC3cXptVWnu7s%3D 20202903 10.1016/j.coph.2010.02.001
122. RB Stoughton 1972 Bioassay system for formulations of topically applied glucocorticosteroids Arch Dermatol 106 825 827 1:CAS:528:DyaE3sXotVWitg%3D%3D 4639246 10.1001/archderm.106.6.825
123. Swingle K (1974) Properties of steroidal anti-inflammatory drugs. In: Scherrer RA, Whitehouse MW (eds) Anti-inflammatory agents, vol II. Academic Press, New York, pp 85-89
124. JS Thompson MR Urist 1973 Effect of cortisone on bone metabolism in intact and thyroidectomized rabbits Calcif Tissue Int 13 197 215 1:CAS:528:DyaE2cXksVahtA%3D%3D 10.1007/BF02015410
125. Trnavsky K (1974) Drug effects on connective tissue metabolism. In: Scherrer RA, Whitehouse MW (eds) Anti-inflammatory agents, vol II. Academic Press, New York, pp 303-326
126. S Van der Laan OC Meijer 2008 Pharmacology of glucocorticoids: beyond receptors Eur J Pharmacol 585 483 491 18410913 10.1016/j.ejphar.2008.01.060 1:CAS:528:DC%2BD1cXls1Sntb4%3D
127. L Wang J Wang KF Almqvist EM Veys G Verbruggen 2002 Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro Clin Exp Rheumatol 20 669 676 1:STN:280:DC%2BD38nlt1SmtQ%3D%3D 12412198 (Pubitemid 35243780)
128. G Weindl M Schellar M Schafer-Korting HC Korting 2004 Hyaluronic acid in the treatment and prevention of skin diseases: molecular, biological, pharmaceutical and clinical aspects Skin Pharmacol Physiol 17 207 213 1:CAS:528:DC%2BD2cXnvFanurc%3D 15452406 10.1159/000080213 (Pubitemid 39370251)
129. G Weissmann L Thomas 1963 Studies on lysosomes II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A J Clin Invest 42 661 669 1:CAS:528:DyaF3sXksFKnurs%3D 13999782 10.1172/JCI104757
130. Whitehouse MW (1964) Some biochemical and pharmacological properties of anti-inflammatory drugs. In: Jucker E (ed) Progress in drug research, vol 8, pp 321-429
131. MW Whitehouse 1967 Evaluation of potential anti-rheumatic drugs in vitro using lymphocytes and epithelial cells J Pharm Pharmacol 19 590 595 1:CAS:528:DyaF2sXltVOitbo%3D 4383451
132. MW Whitehouse 1995 Inflammation, stress and environmental factors as determinants of NSAID efficacy and toxicity Inflammopharmacol 3 373 377 1:CAS:528:DyaK28XhslOlsbk%3D 10.1007/BF02668033 (Pubitemid 26049155)
133. MW Whitehouse 2005 Coxibs and their aftermath: a commentary based on some historical viewpoints Inflammopharmacol 13 403 417 1:CAS:528:DC%2BD2MXht1yntbfM 10.1163/156856005774415600 (Pubitemid 41617802)
134. MW Whitehouse 2005 Prostanoids as friends, not foes: further evidence from the interference by Cox-inhibitory drugs when inducing tolerance to experimental arthritigens in rats Inflammopharmacol 12 481 492 1:CAS:528:DC%2BD2MXht12isLfK 10.1163/156856005774382788 (Pubitemid 41607352)
135. MW Whitehouse 2007 Adjuvant arthritis 50 years on Inflamm Res 56 133 138 1:CAS:528:DC%2BD2sXkvVyquro%3D 17522809 10.1007/s00011-006-6117-8 (Pubitemid 47164933)
136. MW Whitehouse DE Butters 2003 Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products Inflammopharmacol 11 453 464 1:CAS:528:DC%2BD2cXhvFOmsLk%3D 10.1163/ 156856003322699636 (Pubitemid 38175954)
137. MW Whitehouse JW Lash 1961 Effect of cortisone and related compounds on the biogenesis of cartilage Nature 189 37 39 1:CAS:528:DyaF3sXktFSgsr0%3D 13784887 10.1038/189037a0
138. MW Whitehouse KD Rainsford 2006 Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain Inflammopharmacol 14 155 162 10.1007/s10787-006-1523-7 1:CAS:528:DC%2BD28XhtVynsbvL (Pubitemid 44358277)
139. C Xiao J Zhou Y He H Jia L Zhao N Zhao, et al. 2009 Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-kappa B: a study on induced arthritis in rats Chin Med 4 13 19570240 10.1186/1749-8546-4-13 1:CAS:528:DC%2BD1MXotlerurY%3D
140. W Yao Z Cheng C Busse A Pham MC Nakamara NE Lane 2008 Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolong suppression of osteogenesis Arthr Rheum 58 1674 1686 1:CAS:528:DC%2BD1cXotVOntrs%3D 10.1002/art.23454 (Pubitemid 351847520)